TrialInvestigational new drugs2019
Phase II study of avelumab in multiple relapsed/refractory germ cell cancer.
M Mego et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
47 papers cite it
this paperpooled ittrialcites it
TrialInvestigational new drugs2019
M Mego et al.PubMed ↗Publisher ↗
No numbers read from the abstract.